Skip to content
Search

Latest Stories

Boots partners with LIVI to strengthen its digital pharmacy services

Boots UK on Thursday (16) announced a new partnership with digital healthcare provider LIVI to strengthen its digital pharmacy services.

The existing Boots UK and LIVI collaboration of in-store services is expanding as trial of a new online GP and pharmacy video consultation service begins.


The trial has been brought forward to assist patients isolating due to the Covid-19 pandemic.

Richard Bradley, Director of Pharmacy for Boots UK, said: “With millions of patients self-isolating at home – particularly the elderly or those with underlying health conditions – access to expert health advice without having travel to a pharmacy or GP surgery is even more crucial.

“We are pleased to work with innovators like LIVI to continue transforming online and high street access to healthcare advice, medical services and medicines.”

The companies are working together through approved and regulated routes to trial how patients could remotely access a Boots pharmacist via the LIVI app, to get general health advice and to have a conversation face-to-face about their own prescription medications.

This service has the potential to help reduce pressure on the NHS, ensuring that customers maintain simple and safe access to healthcare whilst at home.

The partnership will also see a future expansion of the successful in-store pilot to several new Boots UK stores – the majority of which will deliver NHS commissioned services – in high street locations throughout the country.

Juliet Bauer, UK Managing Director, LIVI, said: “Boots UK shares our ethos that the health system should be responsive to the needs of patients. By tapping into our digital health tech, millions of Boots UK customers will be able to access a more responsive and flexible health service.”

The long-term agreement follows the successful pilot programme in two Boots stores from October 2019. These stores will offer the LIVI video GP service via a tablet in-store, as well as a range of diagnostic tools, such as blood pressure monitoring.

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less